Thermo Fisher Scientific (TMO) Revenue — Quarter Ended Jul 1, 2023
Reported revenue was essentially flat versus the immediately preceding quarter but declined compared to the same quarter one year earlier. The trend shows a progressive deceleration from prior-year growth to consecutive declines.
Key takeaway
Quarter ended Jul 1, 2023 · FY2023 Q2
Reported revenue was essentially flat versus the immediately preceding quarter but declined compared to the same quarter one year earlier. The trend shows a progressive deceleration from prior-year growth to consecutive declines.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$10.7B
Revenue reported for this quarter.
Quarter-over-quarter
-0.2%
Change from the immediately preceding quarter.
Year-over-year
-2.6%
Change from the comparable year-ago quarter.
Trailing four quarters
$43.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Oct 1, 2022 | $10.7B | +14.4% |
| Dec 31, 2022 | $11.5B | +7.0% |
| Apr 1, 2023 | $10.7B | -9.4% |
| Jul 1, 2023 | $10.7B | -2.6% |
Revenue performance
Revenue for the quarter decreased relative to the same period in the prior year, while remaining nearly unchanged from the prior quarter.
Quarterly comparison
Compared with the immediately preceding quarter, revenue showed a negligible decline. Versus the same quarter one year earlier, revenue was lower, continuing the pattern of year-over-year contraction observed in the prior quarter.
What to watch
The persistent year-over-year revenue decline, despite stable sequential performance, warrants monitoring of demand trends and competitive dynamics.